Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Benevento

7 clinical trials in Benevento, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Benevento at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Benevento

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Azienda USL IRCCS Di Reggio Emilia

Study of Palbociclib and Fulvestrant for Women with Advanced Breast Cancer After Previous CDK4/6 Inhibitor and Hormonal Therapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:Consorzio Oncotech

Lung adenocarcinoma

Not recruiting

Durvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Carboplatin
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale

Breast cancer

Not recruiting

Study on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:IRCCS Ospedale Policlinico San Martino

Study on Cetuximab-Based Treatment for Metastatic Colorectal Cancer in Patients with RAS/BRAF Wild Type Tumors

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale

Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB

Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Benevento

What the registry says about research in the country

01 Breast Cancer Research

Innovative studies focusing on endocrine-responsive breast cancer treatment optimization, examining both sequential and concurrent therapy approaches for post-menopausal patients.

  • Hormone Receptor Positive Breast Cancer
  • Adjuvant Treatment Strategies
  • CDK4/6 Inhibitor Therapy

Advanced research exploring combination therapies with palbociclib and fulvestrant for patients with metastatic disease.

02 Colorectal Cancer Studies

Groundbreaking research in metastatic colorectal cancer treatment, focusing on biomarker-driven approaches and targeted therapies.

  • RAS/BRAF Wild Type Tumors
  • Cetuximab-Based Treatment
  • Liquid Biopsy Analysis

Comparative studies of bevacizumab and cetuximab combinations in first-line therapy settings.

03 Lung Cancer Trials

Advanced clinical research examining non-small cell lung cancer treatments in post-surgical settings.

  • Adjuvant Immunotherapy
  • PD-L1 Expression Studies
  • Stage IB-IIIA Disease

Evaluation of MEDI4736 in completely resected cases, focusing on disease-free survival outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.